134 related articles for article (PubMed ID: 9248871)
1. Does plasma free-3-methoxy-4-hydroxyphenyl(ethylene)glycol increase in the delirious state? A comparison of the effects of mianserin and haloperidol on delirium.
Nakamura J; Uchimura N; Yamada S; Nakazawa Y
Int Clin Psychopharmacol; 1997 May; 12(3):147-52. PubMed ID: 9248871
[TBL] [Abstract][Full Text] [Related]
2. [Effects of mianserin hydrochloride on delirium: comparison with the effects of oxypertine and haloperidol].
Nakamura J; Uchimura N; Yamada S; Nakazawa Y
Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Aug; 14(4):269-77. PubMed ID: 7975931
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of mianserin on symptoms of delirium in the aged: an open trial study.
Uchiyama M; Tanaka K; Isse K; Toru M
Prog Neuropsychopharmacol Biol Psychiatry; 1996 May; 20(4):651-6. PubMed ID: 8843489
[TBL] [Abstract][Full Text] [Related]
4. Effects of mianserin on negative symptoms in schizophrenia.
Mizuki Y; Kajimura N; Imai T; Suetsugi M; Kai S; Kaneyuki H; Yamada M
Int Clin Psychopharmacol; 1990 Apr; 5(2):83-95. PubMed ID: 1696292
[TBL] [Abstract][Full Text] [Related]
5. Effects of clozapine on plasma catecholamines and relation to treatment response in schizophrenia: a within-subject comparison with haloperidol.
Brown AS; Gewirtz G; Harkavy-Friedman J; Cooper T; Brébion G; Amador XF; Malaspina D; Gorman JM
Neuropsychopharmacology; 1997 Nov; 17(5):317-25. PubMed ID: 9348547
[TBL] [Abstract][Full Text] [Related]
6. Platelet alpha-2 adrenergic receptor binding and plasma free 3-methoxy-4-hydroxyphenylethylene glycol in depressed patients before and after treatment with mianserin.
Kaneko M; Kanno T; Honda K; Mashiko H; Oosuga N; Watanabe A; Kumashiro H
Neuropsychobiology; 1992; 25(1):14-9. PubMed ID: 1318513
[TBL] [Abstract][Full Text] [Related]
7. Olanzapine in the treatment of delirium.
Sipahimalani A; Masand PS
Psychosomatics; 1998; 39(5):422-30. PubMed ID: 9775699
[TBL] [Abstract][Full Text] [Related]
8. Monoamine metabolites in cerebrospinal fluid of depressed patients during treatment with mianserin or amitriptyline.
Mendlewicz J; Pinder RM; Stulemeijer SM; Van Dorth R
J Affect Disord; 1982 Sep; 4(3):219-26. PubMed ID: 6182175
[TBL] [Abstract][Full Text] [Related]
9. Plasma catecholamine metabolites and early response to haloperidol.
Bowers MB; Swigar ME; Jatlow PI; Goicoechea N
J Clin Psychiatry; 1984 Jun; 45(6):248-51. PubMed ID: 6725216
[TBL] [Abstract][Full Text] [Related]
10. Association of plasma free-3-methoxy-4-hydroxyphenyl (ethylene)glycol, natural killer cell activity and delirium in postoperative patients.
Nakamura J; Yoshimura R; Okuno T; Ueda N; Hachida M; Yasumoto K; Egami H; Maeda H; Nishi M; Aoyagi S
Int Clin Psychopharmacol; 2001 Nov; 16(6):339-43. PubMed ID: 11712622
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of concomitant setiptiline maleate (Tecipul) on negative symptoms of schizophrenia.
Kuniyoshi M; Nakamura J; Miura C; Inanaga K
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Mar; 18(2):339-46. PubMed ID: 7516085
[TBL] [Abstract][Full Text] [Related]
12. Plasma catecholamine metabolites and treatment response at neuroleptic steady state.
Bowers MB; Swigar ME; Jatlow PI; Hoffman FJ
Biol Psychiatry; 1989 Mar; 25(6):734-8. PubMed ID: 2923935
[TBL] [Abstract][Full Text] [Related]
13. Plasma catecholamine metabolites in schizophrenics: evidence for the two-subtype concept.
Chang WH; Chen TY; Lin SK; Lung FW; Lin WL; Hu WH; Yeh EK
Biol Psychiatry; 1990 Mar; 27(5):510-8. PubMed ID: 2310806
[TBL] [Abstract][Full Text] [Related]
14. Acute effects of neuroleptics on unmedicated schizophrenic patients and controls.
Miller AL; Maas JW; Contreras S; Seleshi E; True JE; Bowden C; Castiglioni J
Biol Psychiatry; 1993 Aug; 34(3):178-87. PubMed ID: 8104509
[TBL] [Abstract][Full Text] [Related]
15. Bupropion slow-release response in depression: diagnosis and biochemistry.
Goodnick PJ; Dominguez RA; DeVane CL; Bowden CL
Biol Psychiatry; 1998 Oct; 44(7):629-32. PubMed ID: 9787888
[TBL] [Abstract][Full Text] [Related]
16. Olanzapine vs haloperidol: treating delirium in a critical care setting.
Skrobik YK; Bergeron N; Dumont M; Gottfried SB
Intensive Care Med; 2004 Mar; 30(3):444-9. PubMed ID: 14685663
[TBL] [Abstract][Full Text] [Related]
17. [Psychiatry and sleep disorders--delirium].
Ito H; Harada D; Hayashida K; Ishino H; Nakayama K
Seishin Shinkeigaku Zasshi; 2006; 108(11):1217-21. PubMed ID: 17375454
[No Abstract] [Full Text] [Related]
18. Predicting haloperidol treatment response in chronic schizophrenia.
van Kammen DP; Kelley ME; Yao JK; Gilbertson MW; Gurklis JA; Inosaka T; Saito H; Peters JL; Sato M
Psychiatry Res; 1996 Aug; 64(1):47-58. PubMed ID: 8888364
[TBL] [Abstract][Full Text] [Related]
19. Pharmacoclinical correlations in schizophrenic patients treated with haloperidol decanoate: clinical evaluations, concentrations of plasma and red blood cell haloperidol and its reduced metabolite, and plasma homovanillic acid.
Aymard N; Viala A; Stein I; Caroli F
Prog Neuropsychopharmacol Biol Psychiatry; 1995 Nov; 19(7):1119-35. PubMed ID: 8787036
[TBL] [Abstract][Full Text] [Related]
20. Haloperidol response and plasma catecholamines and their metabolites.
Green AI; Alam MY; Boshes RA; Waternaux C; Pappalardo KM; Fitzgibbon ME; Tsuang MT; Schildkraut JJ
Schizophr Res; 1993 Jun; 10(1):33-7. PubMed ID: 8369230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
